Lo que hay que ver en Amsterdam

Se aproxima el congreso de la ESC de 2013 en Amsterdam y es interesante saber que habrá de nuevo.  El Dr. Keith Fox comenta los detalles para The Heart. Hot […]

Se aproxima el congreso de la ESC de 2013 en Amsterdam y es interesante saber que habrá de nuevo.  El Dr. Keith Fox comenta los detalles para The Heart.

Hot Line I: Late Breaking Trials on Thrombosis (September 1)

Chairpersons: Panagiotis VARDAS (Heraklion, GR), Keith FOX (Edinburgh, GB)

Treatment of venous thromboembolism, the Hokusai VTE study-Harry BULLER (Amsterdam, NL)

TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trial- Ole FROBERT (Orebro, SE)

TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy- Philippe Gabriel STEG (Paris Cedex, FR)

RE-ALIGN: Dabigatran in patients with a mechanical heart valve- Frans VAN DE WERF (Leuven, BE)

PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention: Two-Year Results from the Patterns of Non-Adherence to Anti-Platelet Regimens In Stented Patients (PARIS) Study- Roxana MEHRAN (New York, US)

Hot Line II: Late Breaking Trials on Intervention and devices (September 1)

Chairpersons: Mariell JESSUP (Philadelphia, US), Fausto Jose PINTO (Lisbon, PT)

PRAMI: Preventive Angioplasty in Myocardial Infarction Trial- David WALD (London, GB)

ACCOAST: A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction- Gilles MONTALESCOT (Paris, FR)

DECAAF: Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF): Analysis of post ablation scar and outcome- Nassir MARROUCHE (Salt Lake City, US)

PRAGUE 14: Perioperative ischemia versus perioperative bleeding in consecutive cardiac patients undergoing non-cardiac surgery- Petr WIDIMSKY (Prague, CZ)

LINC study: LINC - A multicenter randomized trial comparing a mechanical CPR algorithm using LUCAS vs. manual CPR in out-of-hospital cardiac arrest patients- Sten RUBERTSSON (Uppsala, SE)

IN-TIME Study - The Influence of Implant-Based Home Monitoring on the Clinical Management of Heart Failure Patients with an Impaired Left Ventricular Function-Gerhard HINDRICKS (Leipzig, DE)

Hot Line III: Late Breaking Trials on Risk factors and Diabetes (September 2)

Chairpersons: Jeroen BAX (Leiden, NL), John Gordon HAROLD (Los Angeles, US)

PURE: Contrasting associations between risk factor burden, CVD incidence and mortality in high, middle and low income countries- Salim YUSUF (Hamilton, CA)

EXAMINE: EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome- William B WHITE (Farmington, US)

SAVOR-TIMI 53: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 Study- Deepak BHATT (Newton, US)

ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE Study- Stephen James NICHOLLS (Adelaide, AU)

COMPARE: Effect of losartan on aortic dilatation rate in adults with Marfan Syndrome- Barbara Jm MULDER (Amsterdam, NL)

Hot Line IV: Late Breaking Trials on Heart Failure and Acute Coronary Syndrome (September 3)

Chairpersons: Donna ARNETT (Birmingham, US), Michel KOMAJDA (Paris, FR)

Centenary of the Tour de France Group: Mortality of French Participants from the Tour de France 1947-2012- Xavier JOUVEN (Paris, FR)

ATOMIC-AHF: Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: Results from ATOMIC-AHF- John R TEERLINK (San Francisco, US)

EchoCRT: EchoCRT: Echocardiography guided Cardiac Resynchronization Therapy in patients with narrow QRS- Frank RUSCHITZKA (Zurich, CH)

AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study Results- Stephen James NICHOLLS (Adelaide, AU)

BIC-8: Instant early rule-out using cardiac troponin and copeptin in low- to intermediate-risk patients with suspected ACS: A prospective, randomized multicenter study- Martin MOECKEL (Berlin, DE)

También se presentaran nuevos datos sobre: RELAX-AHF, PARTNER, Symplicity HTN-1, CHAMPION, RAFT y ORIGIN.

Esperamos poder "postear"  lo que sucede en Amsterdam la próxima semana.  Así que stay tune folks.


Para más información consultar esta entrada en The Heart, donde el Dr. Keith Fox explica con más detalle las novedades del próximo congreso de la ESC.

Primero visto en:  The Heart.

Comments Closed

Comments are closed. You will not be able to post a comment in this post.